Developer docs
API playgroundTry for free, no card

Search company profiles

HeartVista

Full company profile

uuid000e911

Namestring
HeartVista
Legal namestring
Vista AI, Inc.
Websiteurl
heartvista.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

HeartVista, Inc., now doing business as Vista AI, is a privately held medical imaging AI software company founded in 2012 and headquartered at 702 Marshall St, Suite 280, Redwood City, California. The company builds Vista AI Scan, an FDA 510(k)-cleared software platform that automates cardiac MRI acquisition. The product uses computer vision and process-automation AI to analyze MRI images in real time, guide technologists through scan positioning and parameter selection, and enforce consistent image quality across operators and sites, enabling non-specialist technologists to perform high-quality cardiac MRI exams. The platform is designed to interoperate with MRI scanners from multiple manufacturers, including GE Healthcare and Siemens.

Vista AI sells into hospital radiology departments and imaging centers facing rising imaging demand, technologist staffing shortages, and growing clinical complexity. Its primary customer segment is enterprise health systems; publicly named deployments include Stanford, Brigham and Women's Hospital, Sutter Health, and Radiology Regional. GTM is a direct enterprise field-sales motion with a "Book Demo" funnel, supplemented by clinical case studies, a content/resource hub, newsroom PR, and corporate LinkedIn and X channels. Revenue is generated via subscription / recurring software licensing of the FDA-cleared platform to healthcare providers, with pricing not publicly disclosed.

The company is venture-backed and pre-IPO, and reported headcount of 11–50 employees. In March 2024 it appointed MedTech veteran Daniel Hawkins as CEO and in September 2023 added Steve Cashman to its board. December 2024 publication of two-year clinical data — 26% faster CMR scan times, 50% more scan slots, and a 28-day-to-1-day backlog reduction — anchors the commercial value proposition. The company has signaled plans to extend the automation architecture beyond cardiac MRI into additional anatomies, broadening the addressable procedure footprint of the platform.

Short descriptiontext

HeartVista, now DBA Vista AI, is a privately held, FDA 510(k)-cleared medical imaging AI software company that automates cardiac MRI acquisition for hospital radiology departments and imaging centers using real-time computer vision, enabling faster, more consistent scans across sites and operators.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRedwood City, United States
HQ citystring
Redwood City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
MRI acquisition software, AI-powered imaging, cardiac MRI automation, radiology workflow software, medical imaging AI
Industry3 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAKABAE
Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Licensing
TypeSubscription Recurring
Description

FDA-cleared AI software licensing model where healthcare systems pay for access to Vista AI Scan technology to enable automated MRI scanning capabilities.

vista.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Vista AI Scan
Description

FDA-cleared automated cardiac MRI scanning software that enables existing staff to deliver consistent, high-quality imaging across sites of service.

vista.ai
Core offering1 text field

HeartVista (operating as Vista AI, Inc.) develops and licenses Vista AI Scan, an FDA-cleared AI-powered automated MRI acquisition software that performs and guides cardiac MRI scanning. The product enables any technologist at any site to deliver consistent, reproducible, high-quality cardiac MRI exams without requiring specialist radiology expertise, and is sold as enterprise software to hospitals, health systems, and imaging centers using MRI scanners from manufacturers such as GE Healthcare and Siemens.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 26% faster CMR scan times
+2 more records
Product overview1 text field

Vista AI offers a single unified product: Vista AI Scan, an FDA-cleared AI-powered MRI acquisition software. The platform automates cardiac MRI scanning, enabling healthcare systems to deploy consistent, high-quality cardiac imaging across all their sites without requiring specialist radiologists. The company is expanding its automation platform to other anatomies beyond cardiac MRI.

Product and service1 record
1Vista AI Scan
CategoryMedical imaging AI software
Description

FDA-cleared AI-powered automated MRI acquisition software that enables any technologist to perform high-quality cardiac MRI scans at any site. The software automates scan positioning, parameter optimization, and quality assurance, reducing dependency on specialized radiology expertise and delivering consistent, reproducible results across operators, sites, and MRI scanner manufacturers (GE Healthcare, Siemens). It is sold to hospital radiology departments, integrated delivery networks, and imaging centers.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Subtle Medical develops AI-powered software that accelerates MRI scan times and improves image quality, directly overlapping with Vista AI Scan's core value proposition of faster, more accessible MRI. Both companies target radiology departments seeking workflow efficiency gains.

TypeDirect peer
Description

Aidoc is a leading AI radiology platform offering workflow triage and diagnostic AI across multiple modalities. While broader in scope than Vista, it competes for the same hospital radiology AI budget and procurement slots.

TypeDirect peer
Description

RapidAI provides AI-driven imaging analysis initially focused on stroke and now expanded across neuro, cardiac, and vascular workflows. It is a direct enterprise competitor for cardiac and complex imaging AI budgets at hospital systems.

TypeDirect peer
Description

Arterys (now part of Tempus) pioneered cloud-based AI cardiac MRI analysis, making it historically one of the most directly comparable companies to HeartVista's cardiac MRI focus.

TypeDirect peer
Description

icometrix develops AI solutions for brain MRI quantification and is FDA-cleared, with a similar model of selling AI imaging software to hospital radiology departments for specialized quantitative analysis.

TypeBroad incumbent
Description

GE Healthcare manufactures MRI scanners and offers its own AI-based acceleration (AIR Recon DL) and broader Edison AI platform. It is simultaneously a partner and a major competitive incumbent that controls the scanner ecosystem in which Vista AI integrates.

TypeBroad incumbent
Description

Siemens Healthineers manufactures MRI scanners and ships AI imaging tools (e.g., Deep Resolve, AI-Rad Companion). As both a Vista partner and a deep-pocketed incumbent, it is the principal ecosystem gatekeeper in the European and global MRI market.

TypeBroad incumbent
Description

Philips is a global MRI manufacturer with a growing AI portfolio (IntelliSpace AI). It competes with Vista for AI imaging budgets and could develop or acquire equivalent acquisition-automation functionality.

TypeEmerging player
Description

Annalise.ai offers a comprehensive AI radiology decision-support platform covering chest X-ray, CT, and other modalities. It competes for the same radiology AI purchasing budgets and offers a broader multi-modality value proposition.

TypeEmerging player
Description

Quibim provides AI-powered medical imaging analysis with a focus on MRI biomarkers and quantitative imaging. It targets similar radiology AI use cases in oncology and other specialties, representing an emerging alternative for hospital AI deployments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HeartVista

Medical Imaging Softwareheartvista.com

HeartVista, now DBA Vista AI, is a privately held, FDA 510(k)-cleared medical imaging AI software company that automates cardiac MRI acquisition for hospital radiology departments and imaging centers using real-time computer vision, enabling faster, more consistent scans across sites and operators.

What HeartVista does

HeartVista, Inc., now doing business as Vista AI, is a privately held medical imaging AI software company founded in 2012 and headquartered at 702 Marshall St, Suite 280, Redwood City, California. The company builds Vista AI Scan, an FDA 510(k)-cleared software platform that automates cardiac MRI acquisition. The product uses computer vision and process-automation AI to analyze MRI images in real time, guide technologists through scan positioning and parameter selection, and enforce consistent image quality across operators and sites, enabling non-specialist technologists to perform high-quality cardiac MRI exams. The platform is designed to interoperate with MRI scanners from multiple manufacturers, including GE Healthcare and Siemens.

Vista AI sells into hospital radiology departments and imaging centers facing rising imaging demand, technologist staffing shortages, and growing clinical complexity. Its primary customer segment is enterprise health systems; publicly named deployments include Stanford, Brigham and Women's Hospital, Sutter Health, and Radiology Regional. GTM is a direct enterprise field-sales motion with a "Book Demo" funnel, supplemented by clinical case studies, a content/resource hub, newsroom PR, and corporate LinkedIn and X channels. Revenue is generated via subscription / recurring software licensing of the FDA-cleared platform to healthcare providers, with pricing not publicly disclosed.

The company is venture-backed and pre-IPO, and reported headcount of 11–50 employees. In March 2024 it appointed MedTech veteran Daniel Hawkins as CEO and in September 2023 added Steve Cashman to its board. December 2024 publication of two-year clinical data — 26% faster CMR scan times, 50% more scan slots, and a 28-day-to-1-day backlog reduction — anchors the commercial value proposition. The company has signaled plans to extend the automation architecture beyond cardiac MRI into additional anatomies, broadening the addressable procedure footprint of the platform.

HeartVista firmographics

Firmographics
Name
HeartVista
Legal name
Vista AI, Inc.
Website
https://heartvista.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
HeartVista, now DBA Vista AI, is a privately held, FDA 510(k)-cleared medical imaging AI software company that automates cardiac MRI acquisition for hospital radiology departments and imaging centers using real-time computer vision, enabling faster, more consistent scans across sites and operators.
Ownership category
akta.pro rank

HeartVista industry classification

Industry
Product category
Medical Imaging Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLAKABAE
Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)

Keywords

  • MRI acquisition software
  • AI-powered imaging
  • Cardiac MRI automation
  • Radiology workflow software
  • Medical imaging AI

Where HeartVista is headquartered

Location

Headquarters

HQ city
Redwood City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

HeartVista business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Software Licensing: FDA-cleared AI software licensing model where healthcare systems pay for access to Vista AI Scan technology to enable automated MRI scanning capabilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

HeartVista product offering

Product offering

Core offering

HeartVista (operating as Vista AI, Inc.) develops and licenses Vista AI Scan, an FDA-cleared AI-powered automated MRI acquisition software that performs and guides cardiac MRI scanning. The product enables any technologist at any site to deliver consistent, reproducible, high-quality cardiac MRI exams without requiring specialist radiology expertise, and is sold as enterprise software to hospitals, health systems, and imaging centers using MRI scanners from manufacturers such as GE Healthcare and Siemens.

Product overview

Vista AI offers a single unified product: Vista AI Scan, an FDA-cleared AI-powered MRI acquisition software. The platform automates cardiac MRI scanning, enabling healthcare systems to deploy consistent, high-quality cardiac imaging across all their sites without requiring specialist radiologists. The company is expanding its automation platform to other anatomies beyond cardiac MRI.

Differentiator

Problem solved

Functional benefit

Brands

  • Vista AI Scan: FDA-cleared automated cardiac MRI scanning software that enables existing staff to deliver consistent, high-quality imaging across sites of service.

Products and services

  • Vista AI Scan FDA-cleared AI-powered automated MRI acquisition software that enables any technologist to perform high-quality cardiac MRI scans at any site. The software automates scan positioning, parameter optimization, and quality assurance, reducing dependency on specialized radiology expertise and delivering consistent, reproducible results across operators, sites, and MRI scanner manufacturers (GE Healthcare, Siemens). It is sold to hospital radiology departments, integrated delivery networks, and imaging centers.

Quantifiable outcome

  • 26% faster CMR scan times
  • +2 more outcomes

Companies that use HeartVista

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

HeartVista technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature1 record

HeartVista partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

HeartVista competitors and assessment

Company assessment

Direct peers

  • Subtle Medical: Subtle Medical develops AI-powered software that accelerates MRI scan times and improves image quality, directly overlapping with Vista AI Scan's core value proposition of faster, more accessible MRI. Both companies target radiology departments seeking workflow efficiency gains.
  • Aidoc: Aidoc is a leading AI radiology platform offering workflow triage and diagnostic AI across multiple modalities. While broader in scope than Vista, it competes for the same hospital radiology AI budget and procurement slots.
  • RapidAI: RapidAI provides AI-driven imaging analysis initially focused on stroke and now expanded across neuro, cardiac, and vascular workflows. It is a direct enterprise competitor for cardiac and complex imaging AI budgets at hospital systems.
  • Arterys: Arterys (now part of Tempus) pioneered cloud-based AI cardiac MRI analysis, making it historically one of the most directly comparable companies to HeartVista's cardiac MRI focus.
  • icometrix: icometrix develops AI solutions for brain MRI quantification and is FDA-cleared, with a similar model of selling AI imaging software to hospital radiology departments for specialized quantitative analysis.

Broad incumbents

  • GE Healthcare: GE Healthcare manufactures MRI scanners and offers its own AI-based acceleration (AIR Recon DL) and broader Edison AI platform. It is simultaneously a partner and a major competitive incumbent that controls the scanner ecosystem in which Vista AI integrates.
  • Siemens Healthineers: Siemens Healthineers manufactures MRI scanners and ships AI imaging tools (e.g., Deep Resolve, AI-Rad Companion). As both a Vista partner and a deep-pocketed incumbent, it is the principal ecosystem gatekeeper in the European and global MRI market.
  • Philips Healthcare: Philips is a global MRI manufacturer with a growing AI portfolio (IntelliSpace AI). It competes with Vista for AI imaging budgets and could develop or acquire equivalent acquisition-automation functionality.

Emerging players

  • Annalise.ai: Annalise.ai offers a comprehensive AI radiology decision-support platform covering chest X-ray, CT, and other modalities. It competes for the same radiology AI purchasing budgets and offers a broader multi-modality value proposition.
  • Quibim: Quibim provides AI-powered medical imaging analysis with a focus on MRI biomarkers and quantitative imaging. It targets similar radiology AI use cases in oncology and other specialties, representing an emerging alternative for hospital AI deployments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

HeartVista social profiles

Digital presence

HeartVista financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HeartVista leadership team

Management profile

Number of profiles

Profiles2 records

HeartVista funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HeartVista M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeartVista

What does HeartVista do?

HeartVista (operating as Vista AI, Inc.) develops and licenses Vista AI Scan, an FDA-cleared AI-powered automated MRI acquisition software that performs and guides cardiac MRI scanning. The product enables any technologist at any site to deliver consistent, reproducible, high-quality cardiac MRI exams without requiring specialist radiology expertise, and is sold as enterprise software to hospitals, health systems, and imaging centers using MRI scanners from manufacturers such as GE Healthcare and Siemens.

Is HeartVista a public or private company?

HeartVista is a private company. It is classified as venture growth investor backed and is currently operating.

When was HeartVista founded?

HeartVista was founded in 2012. It employs 11 to 50 people.

Where is HeartVista based?

HeartVista is headquartered in Redwood City, United States, in the North America region.

How does HeartVista make money?

One revenue line is on record: software Licensing.

Who are HeartVista's main competitors?

Direct peers on record are Subtle Medical, Aidoc, RapidAI, Arterys and icometrix. Broad incumbents are GE Healthcare, Siemens Healthineers and Philips Healthcare. Emerging players are Annalise.ai and Quibim.

Does HeartVista have an API?

No public API is recorded for HeartVista.

What industry is HeartVista in?

HeartVista's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireHeartVista, Siemens Healthineers Sign Commercial Agreement to Bring AI-Driven Image Acquisition to Hospital MRI ScannersHeartVista and Siemens Healthineers have entered a joint commercial agreement to co-market an integrated MRI scan protocol that combines HeartVista's AI-driven sequences with Siemens' native sequences. This collaboration utilizes Siemens' Access-i interface to allow third-party device integration, aiming to simplify workflows and expand market adoption for cardiac MRI exams. The partnership addresses previous limitations by enabling hospitals to automate complex scans across different vendor technologies.PR NewswireHeartVista Names Bruce Armstrong of Khosla Ventures to Board of DirectorsHeartVista named Bruce Armstrong, a Khosla Ventures partner, to its board of directors. The appointment comes as the company sees significant adoption of its AI-assisted MRI products. Armstrong will help leverage recent breakthroughs to accelerate sales growth and product innovation.Pulse 2.0AI-Assisted MRI Solutions Company HeartVista Raises $8.65 MillionHeartVista raised $8.65 million in Series A funding led by Khosla Ventures, bringing total funding to $16.35 million. The funds will support AI-guided musculoskeletal and neural packages, global expansion, and free software during the pandemic. The company's One-Click Cardiac Package received first place at the ISMRM Machine Learning Workshop in 2018.FinSMEsHeartVista Raises $8.65M in Series A FinancingHeartVista, a Los Altos-based AI-assisted MRI provider, closed an $8.65M Series A round led by Khosla Ventures and others. Combined with NIH grants, total funding reaches $16.35M. The capital will fund AI-guided musculoskeletal and neural packages, global expansion, and strategic partnerships.HIT ConsultantHeartVista Raises $8.65M to Expand One Click, AI-Guided MRI PlatformHeartVista closed an $8.65M Series A led by Khosla Ventures, Jeff Rothschild, Leslie Ventures, and Open Field Capital, bringing total funding to $16.35M. The company will use the funds to develop AI-guided musculoskeletal and neural products, expand internationally, and deepen partnerships with cardiology centers. It will also offer free software during the COVID-19 pandemic.Business Wire BlogHeartVista Closes $8.65M Series A Financing Led by Khosla VenturesHeartVista closed an $8.65M Series A financing round led by Khosla Ventures, bringing total funding to $16.35M. The capital will fund AI-guided musculoskeletal and neural packages, expand sales and regulatory operations, and offer free MRI software during the pandemic.VC News DailyHeartVista Receives $8.65MHeartVista, a Los Altos-based AI-assisted MRI software company, announced the closing of an $8.65 million Series A financing round led by Khosla Ventures, Jeff Rothschild, Leslie Ventures, and Open Field Capital, bringing its total funding to $16.35 million. The capital will fund development of AI-guided musculoskeletal and neural packages, global expansion of sales, marketing and regulatory operations, and enhancement of its One-Click™ Cardiac Package. The company also committed to offering free software usage and remote cardiac scanning services to hospitals during the COVID-19 pandemic to address operational constraints and capacity limitations.PR NewswireHeartVista announces the first AI-driven, One Click ™ Autonomous MRI Solution to Enable Faster and More Efficient Scans that Benefit Patients, Technicians, and RadiologistsHeartVista announced its AI-driven, One-Click Autonomous MRI acquisition software for cardiac exams, which allows MRI technologists to perform cardiac ischemia exams in under 15 minutes compared to the traditional 90-minute session. The software uses artificial intelligence to automatically prescribe standard cardiac views in as little as 10 seconds, incorporates artifact detection, and provides smart in-line cardiac analysis. HeartVista is introducing the solution at the Radiological Society of North America annual meeting in Chicago, with certain features pending FDA 510(k) premarket clearance.